ABOUT US

About Dr. Yogesh Singh


Dr. Yogesh Singh is a Rheumatoid Arthritis Doctor in Dehradun and Immunologist & runs one of the Best Rheumatism Centre In Dehradun. More than 15 years of experience makes him, specialized in the field of autoimmunity and rheumatology. He has done MD (Internal Medicine) from the Kasturba Medical College, Manipal University. Kasturba Medical College has been ranked among the top medical schools in India. is one of the top medical schools. Dr. Singh has done DM (Clinical Immunology) from Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI), Lucknow.

SGPGI is one of the premier medical institutes in India. SGPGI provides one of the best training programs for rheumatology and immunology in the world. The faculty at the Department of Immunology, SGPGI is world-renowned and training under them provides an excellent opportunity for learning. SGPGI caters to a population, which is larger than Europe. Training at SGPGI provides exposure to a wide variety of rheumatic conditions and provides a very invaluable experience in the diagnosis and treatment of rheumatic diseases.

Best Rheumatologist in Dehradun | Dr. Yogesh Singh

Dr. Yogesh Singh

Best Rheumatologist in Dehradun | Dr. Yogesh Singh

Dr. Yogesh Singh spent nearly 6 years at SGPGI. Training at SGPGI is unique. At SGPGI, in addition to rheumatology, the students are taught basic immunology and laboratory immunology. Learning basic immunology is important in understanding the disease process, understanding treatment interventions. Training in lab immunology provides a unique perspective with regards to understanding lab tests, interpreting lab tests, and the fallacies associated with each lab test.

He has received numerous internal scholarships and has numerous international publications to his name. He is the recipient of the (APLAR) Asia Pacific League of Association for Rheumatology Fellowship for the year 2012. As a part of the APLAR fellowship, Dr. Yogesh Singh worked as a research fellow at the department of rheumatology, Southend University Hospital, Southend-on-sea, UK. Department of Rheumatology, Southend University Hospital is a center for excellence on large vessel vasculitis and Polymyalgia Rheumatica. Dr. Singh has also spent time as a visiting research fellow under Dr. David Jayne at Lupus and Vasculitis Clinic, Addenbrooke’s Hospital, Cambridge, UK.

Dr. Yogesh Singh was previously appointed as a Consultant Rheumatologist at Columbia Asia Hospitals, Dehradun. His areas of interest are connective diseases like SLE (Lupus), Scleroderma (Systemic sclerosis), Myositis, and systemic vasculitis. He is associated with the Indian Rheumatology Association and Clinical Immunology Society of India as a member. Dr. Yogesh Singh is a Rheumatoid Arthritis Doctor in Dehradun, he is a compassionate human being. He believes in patient empowerment; practicing ethical and evidence-based medicine at the Best Rheumatology Centre.


Rheumatologist in Dehradun

Professional Experience

  • Adjunct Visiting Professor, Department of Medicine, Kasturba Medical College: June 2016 – till date.
  • Assistant Editor, Indian Journal of Rheumatology: Feb 2016 – till date.
  • Head of the Department, Department of Rheumatology, Manipal Hospital, Old Airport Road, Bangalore: Aug 2014 – till date.
  • Consultant rheumatologist, Manipal Hospital, Malleshwaram, Bangalore: Dec 2013 – Feb 2021.
  • Consultant rheumatologist in Bangalore, Manipal hospital, old airport road: Aug 2013 to Feb 2021.
  • Visiting research fellow, Lupus and Vasculitis Clinic, Addenbrooke’s Hospital, Cambridge, U.K. – May 2013 to June 2013.
  • Visiting research fellow (APLAR fellow), Dept. of Rheumatology, Southend University Hospital, Southend-on-sea, U.K. – Nov 2012 to April 2013.
  • Consultant Rheumatologist, Columbia Asia Referral Hospital – Yeshwantpur, Bangalore and Columbia Asia Hospital, Hebbal, Bangalore: Nov 2010 to Oct 2012
  • Senior Resident, Dept. of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow: January 2005 to June 2010
  • Senior Resident, Dept. of Rheumatology, Manipal Hospital, Bangalore: July 2004 to December 2005.
  • Senior resident, ChanRe Rheumatology & Immunology Center & Research: January 2004 to February 2004.
  • Senior Resident (Honorary): August 2003 to December 2004, Dept. of Immunology, M.S.Ramaiah Medical College, Bangalore, India.
  • Junior Resident, Dept. Of Medicine, Kasturba Medical College, Mangalore: August 2000 to July 2003.
  • Internship, Sree Siddhartha Medical College Hospital, Tumkur: October 1998 to October 1999.

Other Experience

  • Part of the ACR and EULAR guidelines panel for treatment recommendations in the management of polymyalgia rheumatic. (ACR – American College of Rheumatology; EULAR – European league against rheumatism).

Publications

1. Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real-time clinical experience from India. Rheumatol Int. 2019 Jan 25. DOI: 10.1007/s00296-019-04245-4.
2. Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India. Int J Rheum Dis. 2018 Aug 30. DOI: 10.1111/1756-185X.13376. [Epub ahead of print] PubMed PMID: 30168281.
3. Arthritis in Sarcoidosis Group (ASG) – Arthritis in sarcoidosis: A multicentric study from India. Int J Rheum Dis. 2018 Sep;21(9):1728-1733.
4. Effectiveness of a 1-day workshop on scientific writing conducted by the Indian Journal of rheumatology. Indian J Rheumatol 2018;13:117-20
5. Prescribing patterns and safety of biologics in immune-mediated rheumatic diseases: Karnataka biologics cohort study group experience. Indian Journal of Rheumatology January 2018. DOI: 10.4103/injr.injr_79_18
6. Comorbidities and related factors in rheumatoid arthritis patients of South India- Karnataka Rheumatoid Arthritis Comorbidity (KRAC) study. Reumatismo. 2017 Aug 3;69(2):47-58
7. Methotrexate-induced pancytopenia: a case series of 46 patients. 2017 Jul;20(7):846-851
8. Reduced incidence of extra-articular manifestations of RA through effective disease control: Karnataka Rheumatoid Arthritis Comorbidity (KRAC) study
Int J Rheum Dis. 2017 Nov;20(11):1694-1703
9. Factors influencing remission in rheumatoid arthritis patients: results from Karnataka rheumatoid arthritis comorbidity (KRAC) study. Int J Rheum Dis. 2016 Jul 25. DOI: 10.1111/1756-185X.12908. [Epub ahead of print]
10. Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative.Ann Rheum Dis 2015;74:1799-1807
11. Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative.Arthritis& Rheumatology 2015 ,67(10) 2569–2580.
12. Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 EULAR-ACR recommendations for the management of polymyalgia rheumatica. Ann Rheum Dis. 2015 Oct;74(10):1808-17. doi:10.1136/annrheumdis-2015-207578.
13. Central nervous system tuberculosis: mimicking neuropsychiatric systemic lupus erythematosus. J Clin Rheumatol. 2012 Mar;18(2):113-4.
14. A modified Juvenile Arthritis Damage Index to improve articular damage assessment in Juvenile idiopathic arthritis – Enthesitis related arthritis (JIA-ERA). Clinical Rheumatology 2012; DOI:10.1007/s10067-011-1928-6.(epub)
15. Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels. Journal of Rheumatology 2011;38(9):1994-9
16. Unusual cause of anemia in scleroderma: Gastric antral vascular ectasia. Indian Journal of Rheumatology 2011;6(3):158 – 163.
17. Cryptococcal meningitis in systemic lupus erythematosus—Magnetic resonance imaging is not good. Indian Journal of Rheumatology 2011;6(1): 50-52
18. Evidence of cellular immune response to an outer membrane protein of salmonella Typhimurium in patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis. Journal of Rheumatology 2011;38(1):161-166.
19. Medical image. A case of lumbodynia. N Z Med J. 2009;122:115-7
20. Enthesitis related arthritis in Kikuchi–Fujimoto disease. Modern Rheumatology 2008; 18:492–495.
21. Rheumatoid arthritis and primary CNS lymphoma. Journal of Clinical Rheumatology 2008; 14:54-5.
22. Joint involvement in Dengue fever. Journal of General Practice 2007; 19: 35-6.
23. Low dose methotrexate-induced pancytopenia. Clinical Rheumatology 2007; 26: 84–87.
24. Eosinophilic fasciitis. Journal Indian Rheumatology Association 2005; 13: 175

Conference abstracts

1. Factors influencing the utilization of total knee replacement in Osteoarthritis Knee- A web-based survey of treating doctors. OACON 2019 (3rd National conference on osteoarthritis) 3rd and 4th August 2019.
2. Gout mimicking flare of osteoarthritis. OACON 2019 (3rd National conference on osteoarthritis) 3rd and 4th August 2019.
3. Paraneoplastic syndromes as rheumatic disorders (IRACON 2018). Indian Journal of Rheumatology 2018 S(2) P 235.
4. Leflunomide in Takayasu’s arteritis (IRACON 2018). Indian Journal of Rheumatology 2018 S(2) P 221.
5. Maternal and fetal outcomes of lupus pregnancies: Collective effort by Karnataka rheumatologists (IRACON 2018). Indian Journal of Rheumatology 2018 S(2) P 216.
6. Isolated mitochondrial myopathy (IRACON 2018).Indian Journal of Rheumatology 2018 S(2) P 205.
7. Metastatic breast cancer mimicking polymyalgia rheumatic (IRACON 2018). Indian Journal of Rheumatology 2018 S(2) P 204.
8. Maternal and fetal outcomes of lupus pregnancies: Collective effort by Karnataka rheumatologists. SZIRACON 2018 – 24th to 26th April 2018.
9. Arthritis In Sarcoidosis – A Multi-Centre Study (IRACON 2017). Indian Journal of Rheumatology 2017 S(1) P 109.
10. Tuberculosis profile in Biologics experienced patients- Karnataka Biologics Cohort (KBC) Study Group experience (IRACON 2016). Indian Journal of Rheumatology 2016 S(1) P 43.
11. Prescribing patterns and safety of Biologics & Biosimilars in Immune-Mediated Rheumatic Diseases: Karnataka Biologics Cohort (KBC) Study Group experience (IRACON 2016). Indian Journal of Rheumatology 2016 S(1) P 45.
12. Arthritis In Sarcoidosis – A Multi-Centre Study (IRACON 2016). Indian Journal of Rheumatology 2016 S(1) P 72.
13. Methotrexate induced pancytopenia- our experience of 46 patients in 20 years (APLAR 2015). International Journal of Rheumatic Diseases 2015; 18 (Suppl. 1) P 103.
14. Arthritis in sarcoidosis – a multi-center study (APLAR 2015). International Journal of Rheumatic Diseases 2015; 18 (Suppl. 1) P41.
15. Current evidence on prognostic factors in patients with polymyalgia rheumatic (PMR): A systematic literature review informing the ACR/EULAR recommendations for the management of PMR (EULAR 2014). Ann Rheum Dis 2014;73(Suppl2).
16. Current evidence for the therapeutic intervention in polymyalgia rheumatic (PMR): A systematic review informing the ACR/EULAR recommendations for the management of PMR (EULAR 2015). Ann Rheum Dis 2014;73(Suppl2).
17. Polymyalgia Rheumatica: Prioritization of Outcome Measures e Perspective of Patients, General Practitioners, and Rheumatologists (IRACON 2013). Indian journal of rheumatology 2013;8; S3.
18. Isolated Anti-Ro52 Antibody – Significance and Clinical Association. (IRACON 2013) Indian journal of rheumatology 2013;8; S29.
19. Developing Guideline for Polymyalgia Rheumatica: Prioritisation of Outcome Measures – Perspective of Patients, General Practitioners and Rheumatologists (ACR 2013). Arthritis and rheumatism 2013;65(10) S703.
20. Isolated Anti-Ro52 Antibody – Significance and Clinical Association (ACR 2013). Arthritis and rheumatism 2013;65(10) S869
21. A multicenter retrospective analysis of male lupus on the first presentation to a rheumatology clinic. Indian journal of rheumatology 2012, 7 (supply ): S12.
22. Kerato-conjunctivitis sicca and juvenile idiopathic arthritis (IRACON 2012). Indian Journal of Rheumatology 2011;6(3) S17.
23. Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels (Pediatric Rheumatology European Society (PReS) Congress). Pediatric Rheumatology 2011, 9(Suppl 1): P179.
24. Disease phenotype in adults with enthesitis-related arthritis subtype of juvenile idiopathic arthritis (IRACON 2010). Indian Journal of Rheumatology 2010;5(3) S9.
25. Methotrexate induced pancytopenia: Need for increased awareness amongst Primary care physicians (IRACON 2010). Indian Journal of Rheumatology 2010;5(3) S19.
26. Vishwanath V, Singh YP, Lawrence A, Agarwal V, MisraR, Aggarwal A. Male lupus: A retrospective data review (IRACON 2019). Indian Journal of Rheumatology 2010;5(3) S19.
27. Singh YP, Aggarwal.Immune response to an outer membrane protein of Enterobacteriaceae in patients with enthesitis-related arthritis (APLAR 2010). International Journal of Rheumatic Diseases 2010; 13 (Suppl. 1): 59–60.
28. Singh YP, Aggarwal A. Is there a need to modify the juvenile arthritis damage index (JADI) for damage assessment in Juvenile idiopathic arthritis – Enthesitis related arthritis (JIA-ERA)? (APLAR 2010). International Journal of Rheumatic Diseases 2010; 13 (Suppl. 1): 198–202.
29. Singh YP, Singh AK, Aggarwal A, Misra RN. Immune response to an outer membrane protein of S. Typhimurium in patients with JIA-ERA (IRACON 2009). Indian Journal of Rheumatology 2009; 4(3): S6.

IRACON – Annual conference of Indian rheumatology association
APLAR – Annual conference of Asia pacific league against rheumatism